EA015250B9 - Tablets of sildenafil providing modified pharmaceutics and method for preparing thereof - Google Patents

Tablets of sildenafil providing modified pharmaceutics and method for preparing thereof

Info

Publication number
EA015250B9
EA015250B9 EA201001679A EA201001679A EA015250B9 EA 015250 B9 EA015250 B9 EA 015250B9 EA 201001679 A EA201001679 A EA 201001679A EA 201001679 A EA201001679 A EA 201001679A EA 015250 B9 EA015250 B9 EA 015250B9
Authority
EA
Eurasian Patent Office
Prior art keywords
sildenafil
pharmaceutics
tablets
preparing
tablet
Prior art date
Application number
EA201001679A
Other languages
Russian (ru)
Other versions
EA015250B1 (en
EA201001679A1 (en
Inventor
Мая Михочи
Original Assignee
Тева Фармасьютикал Индастриз, Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тева Фармасьютикал Индастриз, Лтд. filed Critical Тева Фармасьютикал Индастриз, Лтд.
Priority to EA201001679A priority Critical patent/EA015250B9/en
Publication of EA015250B1 publication Critical patent/EA015250B1/en
Publication of EA201001679A1 publication Critical patent/EA201001679A1/en
Publication of EA015250B9 publication Critical patent/EA015250B9/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to medicine, in particular to pharmaceutical industry and provides a tablet for the treatment of male erectile dysfunction comprising sildenafil or a pharmaceutically acceptable salt thereof as an active substance. The tablet also comprises hydroxypropylcellulose and colloid anhydrous silicon dioxide and film-coated. The invention also provides a method for manufacturing the tablet and use thereof for the treatment of male erectile dysfunction. According to the invention is characterized by modified pharmaceutics in case of single oral administration.
EA201001679A 2010-11-19 2010-11-19 Tablets of sildenafil providing modified pharmaceutics and method for preparing thereof EA015250B9 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA201001679A EA015250B9 (en) 2010-11-19 2010-11-19 Tablets of sildenafil providing modified pharmaceutics and method for preparing thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201001679A EA015250B9 (en) 2010-11-19 2010-11-19 Tablets of sildenafil providing modified pharmaceutics and method for preparing thereof

Publications (3)

Publication Number Publication Date
EA015250B1 EA015250B1 (en) 2011-06-30
EA201001679A1 EA201001679A1 (en) 2011-06-30
EA015250B9 true EA015250B9 (en) 2013-10-30

Family

ID=44356420

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001679A EA015250B9 (en) 2010-11-19 2010-11-19 Tablets of sildenafil providing modified pharmaceutics and method for preparing thereof

Country Status (1)

Country Link
EA (1) EA015250B9 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA004068B1 (en) * 1998-10-23 2003-12-25 Пфайзер Рисерч Энд Дивелопмент Компани Н.В./С.А. Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor
UA9883U (en) * 2005-04-15 2005-10-17 Pharcos Pharmaceutical Company Tablet for treating erectile dysfunction
BG108969A (en) * 2004-12-08 2006-06-30 "Софарма" Ад Medicamentous form of sildenafil
RU2285520C2 (en) * 2002-02-07 2006-10-20 Фармация Корпорейшн Pharmaceutical dosed formulation for delivery through mucosa

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA004068B1 (en) * 1998-10-23 2003-12-25 Пфайзер Рисерч Энд Дивелопмент Компани Н.В./С.А. Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor
RU2285520C2 (en) * 2002-02-07 2006-10-20 Фармация Корпорейшн Pharmaceutical dosed formulation for delivery through mucosa
BG108969A (en) * 2004-12-08 2006-06-30 "Софарма" Ад Medicamentous form of sildenafil
UA9883U (en) * 2005-04-15 2005-10-17 Pharcos Pharmaceutical Company Tablet for treating erectile dysfunction

Also Published As

Publication number Publication date
EA015250B1 (en) 2011-06-30
EA201001679A1 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
NZ631100A (en) Soft chewable pharmaceutical products
PH12014502271A1 (en) Composite formulation comprising multi-unit spheroidal tablet (must) encapsulated in hard capsule and method for preparing same
WO2014027975A3 (en) Novel orally administered pharmaceutical formulations
PH12014502447A1 (en) Use of high dose laquinimod for treating multiple sclerosis
NZ595467A (en) Sublingual pharmaceutical composition comprising a neutral oil
PH12015500823A1 (en) Modified release formulations for oprozomib
MY157307A (en) Pharmaceutical formulation in the form of bilayered tablets comprising hmg-coa reductase inhibitor and irbersartan
MX2021001905A (en) Pharmaceutical preparation having excellent dissolution properties, containing esomeprazole and sodium bicarbonate.
PH12014501408A1 (en) Immediate release multi unit pellet system
EA201391689A1 (en) SYSTEM OF DELIVERY MEDICINE
MX2015009546A (en) Increased dosage of efavirenz for the treatment of cancer.
MX341660B (en) Ghrelin receptor agonist for treatment of dyscrasia.
JP2015521647A5 (en)
EA015250B9 (en) Tablets of sildenafil providing modified pharmaceutics and method for preparing thereof
WO2011108882A3 (en) Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient
MX2017000384A (en) Capsule dosage form of metoprolol succinate.
MX2014005960A (en) Nitrogen-containing fused ring compounds for use as crth2 antagonists.
PH12016502540A1 (en) Pharmaceutical dosage forms
IN2014CN02343A (en) Oral formulations containing hyaluronic acid for sustained drug release
EA201691763A1 (en) STABLE, QUICKLY SOLUBLE DOSE FORM, CONTAINING AMOXICILLIN AND STOPPING ACID
WO2013054178A3 (en) Extended release pharmaceutical compositions containing carmabazepine
WO2013057569A3 (en) Extended release pharmaceutical composition containing amoxicillin and clavulanic acid
UA97044C2 (en) Agent of antiviral and immunopotentiating activity, process for the preparation thereof and method for the treatment and prevention of infectious diseases
IN2013MU03389A (en)
WO2014064711A3 (en) Methods of administering raltegravir and raltegravir compositions

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM MD TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ BY KG TJ

RH4A Grant of a duplicate of a eurasian patent
TH4A Publication of the corrected specification to eurasian patent